Market Access World USA 2011
Venue: The Westin Grand
Location: Washington, Washington D.C, United States
Event Date/Time: Oct 04, 2011 | End Date/Time: Oct 06, 2011 |
Early Registration Date: Aug 26, 2011 |
Description
•How new reimbursement models will impact market access
•How CER will differ from EU HTA experience
•What is the role of real life/observational studies in the future security of market access
•HTA agency policy and practice globally: comparing and contrasting different models
•Risk sharing, value based pricing, pay for performance
•Quality improvement measures
Speakers include:
Kelly Whitener
Health Policy Advisor
Majority Staff
Senate Finance Committee
Executive Director, Division
of New Health Technology
Assessment
National Evidence-based
Healthcare Collaborating
Agency (NECA), South Korea
Marcus Wilson
President
Healthcare
John J. Kaelin, Senior Vice
President, State Program
Development
UnitedHealth Group
Naomi Aronson
Executive Director, Office of
Clinical Affairs – Technology
Evaluation Center (TEC)
BlueCross BlueShield
Association
Chip Davis, Executive Vice
President Advocacy, PhRMA
Eric Klein, Head of Global HTA and
Outcomes, Eli Lilly
Dr Michael Lauer, Director,
Division of Cardiovascular
Sciences, NIH
And many more
Venue
Additional Information
Restrictions
Trade Only